BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9418159)

  • 1. New mechanisms of viral persistence in primary human immunodeficiency virus (HIV) infection.
    Soudeyns H; Pantaleo G
    J Biol Regul Homeost Agents; 1997; 11(1-2):37-9. PubMed ID: 9418159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection.
    Pantaleo G; Soudeyns H; Demarest JF; Vaccarezza M; Graziosi C; Paolucci S; Daucher MB; Cohen OJ; Denis F; Biddison WE; Sekaly RP; Fauci AS
    Eur J Immunol; 1997 Dec; 27(12):3166-73. PubMed ID: 9464802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
    Wodarz D; Nowak MA
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment.
    Wodarz D; Page KM; Arnaout RA; Thomsen AR; Lifson JD; Nowak MA
    Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):329-43. PubMed ID: 10794051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.
    Brander C; Goulder PJ; Luzuriaga K; Yang OO; Hartman KE; Jones NG; Walker BD; Kalams SA
    J Immunol; 1999 Apr; 162(8):4796-800. PubMed ID: 10202022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
    McKinney DM; Lewinsohn DA; Riddell SR; Greenberg PD; Mosier DE
    J Immunol; 1999 Jul; 163(2):861-7. PubMed ID: 10395680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HIV adaptive immunity: determinants for viral persistence.
    Yamamoto H; Matano T
    Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
    van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
    Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The persistence of CTL memory.
    Wodarz D
    Neth J Med; 2002 Aug; 60(7 Suppl):4-13; discussion 14-6. PubMed ID: 12430586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 lymphocytes in HIV infection: helpful and harmful.
    Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
    J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape.
    Sewell AK; Price DA; Oxenius A; Kelleher AD; Phillips RE
    Stem Cells; 2000; 18(4):230-44. PubMed ID: 10924089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses.
    Bocharov GA
    J Theor Biol; 1998 Jun; 192(3):283-308. PubMed ID: 9650288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD8+ T-cell response in HIV infection.
    Benito JM; López M; Soriano V
    AIDS Rev; 2004; 6(2):79-88. PubMed ID: 15332430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased TCR repertoire in HIV-1-infected patients due to clonal expansion of HIV-1-reverse transcriptase-specific CTL clones.
    Kolowos W; Schmitt M; Herrman M; Harrer E; Löw P; Kalden JR; Harrer T
    J Immunol; 1999 Jun; 162(12):7525-33. PubMed ID: 10358208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
    Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
    Kuribayashi H; Wakabayashi A; Shimizu M; Kaneko H; Norose Y; Nakagawa Y; Wang J; Kumagai Y; Margulies DH; Takahashi H
    Biochem Biophys Res Commun; 2004 Apr; 316(2):356-63. PubMed ID: 15020225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.